- Home
- RCKY vs OBIO Comparison
RCKY vs OBIO Comparison
Compare RCKY & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- OBIO
- Stock Information
- Founded
- RCKY 1932
- OBIO 2017
- Country
- RCKY United States
- OBIO United States
- Employees
- RCKY N/A
- OBIO N/A
- Industry
- RCKY Shoe Manufacturing
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- RCKY Consumer Discretionary
- OBIO Health Care
- Exchange
- RCKY Nasdaq
- OBIO Nasdaq
- Market Cap
- RCKY 155.9M
- OBIO 151.3M
- IPO Year
- RCKY 1993
- OBIO N/A
- Fundamental
- Price
- RCKY $22.78
- OBIO $3.16
- Analyst Decision
- RCKY Hold
- OBIO Strong Buy
- Analyst Count
- RCKY 1
- OBIO 5
- Target Price
- RCKY $20.00
- OBIO $14.20
- AVG Volume (30 Days)
- RCKY 74.1K
- OBIO 192.8K
- Earning Date
- RCKY 04-29-2025
- OBIO 05-12-2025
- Dividend Yield
- RCKY 2.72%
- OBIO N/A
- EPS Growth
- RCKY 2.41
- OBIO N/A
- EPS
- RCKY 1.84
- OBIO N/A
- Revenue
- RCKY $454,939,000.00
- OBIO $2,886,000.00
- Revenue This Year
- RCKY $6.67
- OBIO $21.38
- Revenue Next Year
- RCKY $4.25
- OBIO $31.89
- P/E Ratio
- RCKY $12.39
- OBIO N/A
- Revenue Growth
- RCKY N/A
- OBIO 30.23
- 52 Week Low
- RCKY $11.93
- OBIO $2.37
- 52 Week High
- RCKY $39.65
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- RCKY 67.34
- OBIO 57.83
- Support Level
- RCKY $22.00
- OBIO $2.76
- Resistance Level
- RCKY $23.38
- OBIO $3.02
- Average True Range (ATR)
- RCKY 0.84
- OBIO 0.20
- MACD
- RCKY 0.10
- OBIO 0.05
- Stochastic Oscillator
- RCKY 83.15
- OBIO 94.87
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.